BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 19176795)

  • 1. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
    Bolignano D; Lacquaniti A; Coppolino G; Donato V; Campo S; Fazio MR; Nicocia G; Buemi M
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):337-44. PubMed ID: 19176795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
    Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease.
    Liu KD; Yang W; Anderson AH; Feldman HI; Demirjian S; Hamano T; He J; Lash J; Lustigova E; Rosas SE; Simonson MS; Tao K; Hsu CY;
    Kidney Int; 2013 May; 83(5):909-14. PubMed ID: 23344473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
    Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
    Malyszko J; Malyszko JS; Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
    Transplant Proc; 2009; 41(1):158-61. PubMed ID: 19249502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ; Hu ZX; Li QH; Wang SM; Song CJ; Wu DD; He JL; Guan JC; Shan JP
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
    Bhavsar NA; Köttgen A; Coresh J; Astor BC
    Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.
    Bolignano D; Lacquaniti A; Coppolino G; Campo S; Arena A; Buemi M
    Kidney Blood Press Res; 2008; 31(4):255-8. PubMed ID: 18600028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
    Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
    Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
    Alderson HV; Ritchie JP; Pagano S; Middleton RJ; Pruijm M; Vuilleumier N; Kalra PA
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2141-2149. PubMed ID: 27852662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance.
    McIlroy DR; Wagener G; Lee HT
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):211-9. PubMed ID: 20056755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG
    Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma neutrophil gelatinase-associated lipocalin in acute kidney injury superimposed on chronic kidney disease after cardiac surgery: a multicenter prospective study.
    Doi K; Urata M; Katagiri D; Inamori M; Murata S; Hisagi M; Ono M; Matsubara T; Ishii T; Yahagi N; Nangaku M; Noiri E
    Crit Care; 2013 Nov; 17(6):R270. PubMed ID: 24215663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes.
    Singer E; Elger A; Elitok S; Kettritz R; Nickolas TL; Barasch J; Luft FC; Schmidt-Ott KM
    Kidney Int; 2011 Aug; 80(4):405-14. PubMed ID: 21412214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study.
    Yang YH; He XJ; Chen SR; Wang L; Li EM; Xu LY
    Endocrine; 2009 Aug; 36(1):45-51. PubMed ID: 19390997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study.
    Hollmen ME; Kyllönen LE; Inkinen KA; Lalla ML; Merenmies J; Salmela KT
    Crit Care; 2011; 15(3):R121. PubMed ID: 21545740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension.
    Gharishvandi F; Kazerouni F; Ghanei E; Rahimipour A; Nasiri M
    Iran Biomed J; 2015; 19(2):76-81. PubMed ID: 25864811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
    Lim WH; Lewis JR; Wong G; Teo R; Lim EM; Byrnes E; Prince RL
    Am J Nephrol; 2015; 41(2):156-64. PubMed ID: 25824561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.